cAMP and spore differentiation in Dictyostelium discoideum.

od Kay, R R
Wydane 1982

Sheep Husbandry and Diseases. Fifth Edition

od MacKay, R. R.
Wydane 1969

A specific DIF binding protein in Dictyostelium.

od Insall, R, Kay, R R
Wydane 1990

DIF-1 induces its own breakdown in Dictyostelium.

od Insall, R, Nayler, O, Kay, R R
Wydane 1992

A localized differentiation-inducing-factor sink in the front of the Dictyostelium slug.

od Kay, R R, Large, S, Traynor, D, Nayler, O
Wydane 1993

A myo-inositol D-3 hydroxykinase activity in Dictyostelium.

od Stephens, L R, Kay, R R, Irvine, R F
Wydane 1990

Chlorine-containing compounds produced during Dictyostelium development. Detection by labelling with 36Cl.

od Kay, R R, Taylor, G W, Jermyn, K A, Traynor, D
Wydane 1992

Structure elucidation of two differentiation inducing factors (DIF-2 and DIF-3) from the cellular slime mould Dictyostelium discoideum.

od Morris, H R, Masento, M S, Taylor, G W, Jermyn, K A, Kay, R R
Wydane 1988

An intersection of the cAMP/PKA and two-component signal transduction systems in Dictyostelium.

od Thomason, P A, Traynor, D, Cavet, G, Chang, W T, Harwood, A J, Kay, R R
Wydane 1998

Anaplasmosis: Control of the First Outbreak in Canada by Serological Identification and Slaughter

od Boulanger, P., Ruckerbauer, Gerda M., Bannister, G. L., MacKay, R. R., Peter, N. H.
Wydane 1971

Differentiation-inducing factor from the slime mould Dictyostelium discoideum and its analogues. Synthesis, structure and biological activity.

od Masento, M S, Morris, H R, Taylor, G W, Johnson, S J, Skapski, A C, Kay, R R
Wydane 1988

The proximal pathway of metabolism of the chlorinated signal molecule differentiation-inducing factor-1 (DIF-1) in the cellular slime mould Dictyostelium.

od Morandini, P, Offer, J, Traynor, D, Nayler, O, Neuhaus, D, Taylor, G W, Kay, R R
Wydane 1995

Cloning and expression of the human transient receptor potential 4 (TRP4) gene: localization and functional expression of human TRP4 and TRP3.

od McKay, R R, Szymeczek-Seay, C L, Lievremont, J P, Bird, G S, Zitt, C, Jüngling, E, Lückhoff, A, Putney, J W
Wydane 2000

myo-inositol pentakisphosphates. Structure, biological occurrence and phosphorylation to myo-inositol hexakisphosphate.

od Stephens, L R, Hawkins, P T, Stanley, A F, Moore, T, Poyner, D R, Morris, P J, Hanley, M R, Kay, R R, Irvine, R F
Wydane 1991

A phase II trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer.

od McKay, R. R., Werner, L., Jacobus, S., Jones, A., Mostaghel, E. A., Marck, B. T., Choudhury, A., Pomerantz, M., Sweeney, C., Slovin, S. F., Morris, M. J., Kantoff, P. W., Taplin, M-E.
Wydane w Cancer (2018)

The genome of the social amoeba Dictyostelium discoideum

od Eichinger, L., Pachebat, J.A., Glöckner, G., Rajandream, M.-A., Sucgang, R., Berriman, M., Song, J., Olsen, R., Szafranski, K., Xu, Q., Tunggal, B., Kummerfeld, S., Madera, M., Konfortov, B. A., Rivero, F., Bankier, A. T., Lehmann, R., Hamlin, N., Davies, R., Gaudet, P., Fey, P., Pilcher, K., Chen, G., Saunders, D., Sodergren, E., Davis, P., Kerhornou, A., Nie, X., Hall, N., Anjard, C., Hemphill, L., Bason, N., Farbrother, P., Desany, B., Just, E., Morio, T., Rost, R., Churcher, C., Cooper, J., Haydock, S., van Driessche, N., Cronin, A., Goodhead, I., Muzny, D., Mourier, T., Pain, A., Lu, M., Harper, D., Lindsay, R., Hauser, H., James, K., Quiles, M., Babu, M. Madan, Saito, T., Buchrieser, C., Wardroper, A., Felder, M., Thangavelu, M., Johnson, D., Knights, A., Loulseged, H., Mungall, K., Oliver, K., Price, C., Quail, M.A., Urushihara, H., Hernandez, J., Rabbinowitsch, E., Steffen, D., Sanders, M., Ma, J., Kohara, Y., Sharp, S., Simmonds, M., Spiegler, S., Tivey, A., Sugano, S., White, B., Walker, D., Woodward, J., Winckler, T., Tanaka, Y., Shaulsky, G., Schleicher, M., Weinstock, G., Rosenthal, A., Cox, E.C., Chisholm, R. L., Gibbs, R., Loomis, W. F., Platzer, M., Kay, R. R., Williams, J., Dear, P. H., Noegel, A. A., Barrell, B., Kuspa, A.
Wydane 2005

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

od Grivas, P., Khaki, A.R., Wise-Draper, T.M., French, B., Hennessy, C., Hsu, C.-Y., Shyr, Y., Li, X., Choueiri, T.K., Painter, C.A., Peters, S., Rini, B.I., Thompson, M.A., Mishra, S., Rivera, D.R., Acoba, J.D., Abidi, M.Z., Bakouny, Z., Bashir, B., Bekaii-Saab, T., Berg, S., Bernicker, E.H., Bilen, M.A., Bindal, P., Bishnoi, R., Bouganim, N., Bowles, D.W., Cabal, A., Caimi, P.F., Chism, D.D., Crowell, J., Curran, C., Desai, A., Dixon, B., Doroshow, D.B., Durbin, E.B., Elkrief, A., Farmakiotis, D., Fazio, A., Fecher, L.A., Flora, D.B., Friese, C.R., Fu, J., Gadgeel, S.M., Galsky, M.D., Gill, D.M., Glover, M.J., Goyal, S., Grover, P., Gulati, S., Gupta, S., Halabi, S., Halfdanarson, T.R., Halmos, B., Hausrath, D.J., Hawley, J.E., Hsu, E., Huynh-Le, M., Hwang, C., Jani, C., Jayaraj, A., Johnson, D.B., Kasi, A., Khan, H., Koshkin, V.S., Kuderer, N.M., Kwon, D.H., Lammers, P.E., Li, A., Loaiza-Bonilla, A., Low, C.A., Lustberg, M.B., Lyman, G.H., McKay, R.R., McNair, C., Menon, H., Mesa, R.A., Mico, V., Mundt, D., Nagaraj, G., Nakasone, E.S., Nakayama, J., Nizam, A., Nock, N.L., Park, C., Patel, J.M., Patel, K.G., Peddi, P., Pennell, N.A., Piper-Vallillo, A.J., Puc, M., Ravindranathan, D., Reeves, M.E., Reuben, D.Y., Rosenstein, L., Rosovsky, R.P., Rubinstein, S.M., Salazar, M., Schmidt, A.L., Schwartz, G.K., Shah, M.R., Shah, S.A., Shah, C., Shaya, J.A., Singh, S.R.K., Smits, M., Stockerl-Goldstein, K.E., Stover, D.G., Streckfuss, M., Subbiah, S., Tachiki, L., Tadesse, E., Thakkar, A., Tucker, M.D., Verma, A.K., Vinh, D.C., Weiss, M., Wu, J.T., Wulff-Burchfield, E., Xie, Z., Yu, P.P., Zhang, T., Zhou, A.Y., Zhu, H., Zubiri, L., Shah, D.P., Warner, J.L., Lopes, GdL.
Wydane w Ann Oncol (2021)